Friday, 22 August 2014
Last updated 11 min ago
Oct 3 2012 | 11:52am ET
New York-based NewOak Capital has appointed Donald McGuire chief operating officer and head of investment banking.
McGuire has over 27 years' experience in finance and operations at major investment banking, pharmaceutical, and technology companies around the globe—most recently as managing partner at Greenwich, Conn.-based KDM Advisors. Prior to that, he served as chairman and CEO of Metastatin Pharmaceuticals and before that he was president, COO and director of beenz.com in New York and London and managing director and COO, investment banking-Americas for ING Barings/Furman Selz in New York.
McGuire will direct day-to-day internal operations at NewOak.
"With the continued expansion of NewOak’s efforts in financial advisory and solutions, it is imperative to continue strengthening NewOak’s own governance and operational systems and processes for scalability,” said Ron D'Vari, CEO and co-founder of NewOak, in a statement. “Executing on our client’s complex solutions in investment banking, credit services and financial disputes requires a highly experienced and disciplined team. Don has the right combination of infrastructure and team building track record to help lead such an effort.”
NewOak is an integrated financial advisory and investment banking company providing a range of services to global financial institutions and corporations, institutional investors, law firms and regulatory bodies.
Aug 4 2014 | 7:42am ET
By now, U.S. and international subscribers have received their home or office delivery of the special 500th issue of Futures magazine. You can too!—a very special offer follows. The issue is the largest in years—filled with the best trading strategies and stories from 43 years of being the primary publication for commodity, stock, options and forex traders. Read more…
The July/August 2014 issue is our largest in years—filled with the best trading strategies and stories from 43 years of being the primary publication for commodity, stock, options and forex traders.
The Alpha Pages Editor's Note